		<div class="wpcnt">
			<div class="wpa">
				<span class="wpa-about">Advertisements</span>
				<div class="u top_amp">
							<amp-ad width="300" height="265"
		 type="pubmine"
		 data-siteid="109460728"
		 data-section="1">
		</amp-ad>
				</div>
			</div>
		</div><header id="ra-headers">
<h3 id="ra-headline"><span style="color:#3d0505;">Sanjay Valvani was hit with federal insider trading charges on June 15</span></h3>
<h3><span style="color:#3d0505;">Wife found him lying facedown on bedroom floor of home in at about 6 p.m. Monday</span></h3>
<h3><span style="color:#3d0505;">Valvani, 44, died of an apparent slash wound to the neck. Cops found a suicide note nearby</span></h3>
</header>
<article id="ra-body">A hedge fund manager facing insider-trading charges was found dead in his Brooklyn apartment — the victim of an apparent suicide, officials said.<br />
Sanjay Valvani, 44, was lying facedown on the bedroom floor of his Sidney Place home in Brooklyn Heights when his wife discovered him at about 6 p.m. Monday, according to authorities.<br />
He died of an apparent slash wound to the neck, sources said, adding cops found a knife next to the body along with a suicide note.<br />
“We mourn the tragic loss of Sanjay, a devoted father, husband, and friend,” Jacob Gottlieb, the founder of Visium Asset Management, where Valvani worked, said in a statement. “Our thoughts are with his family during this difficult time.”<br />
On June 15, Valvani was hit with federal insider-trading charges after he was accused of getting advance word about U.S. Food and Drug Administration approvals of generic drugs and using the information to make profitable trades.</p>
<div class="ra-module h">
<figure class="ra-figure"><figcaption>
<h6 class="ra-caption"><img class="alignnone wp-image-38762" src="https://konniemoments.com/wp-content/uploads/2016/06/sanjay-valvani3.jpg" alt="Sanjay Valvani3.jpg" width="716" height="477" />Valvani (left) leaving the Manhattan court after being charged on June 15, 2016</h6>
</figcaption></figure>
</div>
<p>He earned about $25 million on the secret information — and passed on the info to another portfolio manager who made his own illegal trades, authorities said.<br />
Valvani’s lawyer, Barry Berke, accused the U.S. attorney’s office prosecuting the case of “stretching the facts and law to try to transform entirely innocent trading decisions into a crime.”<br />
U.S. Attorney Preet Bharara in Manhattan accused Sanjay Valvani of Visium Asset Management LP of fraudulently making $25 million by gaining advance word about U.S. Food and Drug Administration approvals of generic drug applications.<br />
Prosecutors said the inside information was provided by Gordon Johnston, a consultant who got tips from a friend and former FDA colleague still working at the agency.<br />
Valvani passed some of these tips to Christopher Plaford, then a Visium portfolio manager, who made his own illegal trades, prosecutors said.<br />
&#8220;Sadly these are schemes we see time and time again, where lies and use of non-public information profits those conducting the crimes, and everyday investors lose out,&#8221; FBI Assistant Director-in-Charge Diego Rodriguez said in a statement.<br />
Prosecutors also accused Plaford and Stefan Lumiere, another former Visium portfolio manager, of fraudulently inflating the value and liquidity of a bond fund they oversaw by getting &#8220;sham&#8221; price quotations from brokers, in an effort to prevent investors from demanding their money back.<br />
Visium Asset Management had put Valvani on extended leave after learning he was being investigated, officials said.</p>
</article>

Sanjay Valvani, Hedge fund manager facing insider-trading charges dead from apparent suicide
